MEXICO IN-VITRO DIAGNOSTICS MARKET ANALYSIS

Mexico In-Vitro Diagnostics Market, By Technique (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Techniques), By Product (Instrument, Reagent, and Other Products), By Usability (Disposable IVD Devices and Reusable IVD Devices), By Application (Infectious Diseases, Cancer/Oncology, Cardiology, Autoimmune Disease, Diabetes Nephrology, and Other Applications), and By End User (Diagnostic laboratories, Hospitals and Clinics, and Other End Users) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jun 2022
Code : CMI5049
Pages :169
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Mexico In-Vitro Diagnostics MarketSize and Trends

Market Statistics:

The Mexico in-vitro diagnostics market was valued at US$ 909.4 Mn in 2021 and is forecast to reach a value of US$ 1,540.1 Mn by 2028 at a CAGR of 7.8% between 2022 and 2028.

Figure 1. Mexico In-Vitro Diagnostics Market Share (%), by Technique, 2021

Figure 2. Mexico In-Vitro Diagnostics Market Share (%) in Terms of Value, by Product, 2021

Market Trends/Key Takeaways:

Increasing product launches in the region is expected to drive growth of the Mexico in-vitro diagnostics market during the forecast period. For instance, in June 2021, Bio-Rad Laboratories and Seegene Inc. collaborated for the clinical development and commercialization of infectious disease molecular diagnostic products.
Market players are adopting various growth strategies, such as partnership or collaboration, is expected to drive growth of the Mexico in-vitro diagnostics market over the forecast period. For instance, in October 2020, PerkinElmer Inc. and BioMarin teamed up to enable diagnostic testing for rare diseases in Mexico.